LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

257.27 -0.32

Rezumat

Modificarea prețului

24h

Curent

Minim

252.87

Maxim

259.96

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

38.933

106.172

EPS

1.96

Randament dividend

0.32

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+35.54% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.32%

2.31%

Statistici piață

By TradingEconomics

Capitalizare de piață

-889M

19B

Deschiderea anterioară

257.59

Închiderea anterioară

257.27

Sentimentul știrilor

By Acuity

50%

50%

182 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 nov. 2025, 23:07 UTC

Market Talk

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20 nov. 2025, 22:22 UTC

Market Talk

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20 nov. 2025, 22:08 UTC

Market Talk

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20 nov. 2025, 21:57 UTC

Câștiguri

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20 nov. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Câștiguri

Financial Services Roundup: Market Talk

20 nov. 2025, 21:31 UTC

Câștiguri

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20 nov. 2025, 21:23 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov. 2025, 21:07 UTC

Câștiguri

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:06 UTC

Câștiguri

Webull 3Q Rev $156.9M >BULL

20 nov. 2025, 21:06 UTC

Câștiguri

Webull 3Q EPS 7c >BULL

20 nov. 2025, 21:05 UTC

Câștiguri

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20 nov. 2025, 21:04 UTC

Câștiguri

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20 nov. 2025, 21:04 UTC

Câștiguri

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20 nov. 2025, 21:04 UTC

Câștiguri

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit 1Q Consumer Rev $894M

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Guidance

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit 1Q Global Business Solutions Rev $3B

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

35.54% sus

Prognoză pe 12 luni

Medie 349.56 USD  35.54%

Maxim 375 USD

Minim 311 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

11 ratings

10

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

182 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat